Join us in this live and interactive webinar in which we will learn about immune-mediated hemolytic anemia (IMHA) in dogs - a disease that greatly impacts their wellbeing and that is an important cause of mortality in affected dogs.
This program will serve to empower our audience to make informed decisions regarding the care and management of dogs diagnosed with IMHA. Throughout this 2-part series we will hear perspectives from both an internal medicine and an emergency and critical care specialist. Discussion will include:
- How to recognize possible IMHA and properly diagnose the disease
- How to differentiate important types of IMHA and why this can affect making the diagnosis and treatment recommendations for affected patients
- Medications used for treating IMHA including glucocorticoids, cyclosporine, azathioprine, leflunomide, and mycophenolate mofetil
- Developing treatment plans for dogs requiring immunomodulatory therapy - which drug and when
Fee: FREE for VetVine Premium Membership subscribers
Date:July 23, 2024
Time:7:30 PM US/Eastern
Sponsor:
VetVine
Presenter(s):
John Loftus, PhD, DVM, DACVIM (SAIM and Nutrition), Jethro Forbes, DVM, DACVECC
Fee (Basic Membership):$40
Approved for CE credit for veterinarians and technicians by AAVSB RACE, NY State and the NJVMA.
Be aware that some boards have limitations on the number of hours accepted in certain categories &/or restrictions on certain methods of delivery of CE.
